New CTO and CSO Appointments Drive Innovative Approach to Dialysis Treatment with Moda-flxTM Hemodialysis System

Ravi Parthasarathy Joins Diality as Chief Technology Officer

Diality Inc., a medical device company based in Irvine, California, has announced that Ravi Parthasarathy has joined the company as Chief Technology Officer. With years of experience in product development team leadership, Parthasarathy most recently worked at ICU Medical as Vice President of Device Engineering. Before that, he held leadership roles at Baxter Healthcare, Motorola, Siemens Medical Systems, and General Motors.

Clayton Poppe will also take on the role of Chief Scientific Officer (CSO) to lead the company’s research, quality, and regulatory functions. Osman Khawar, M.D., CEO of Diality expressed his excitement about Parthasarathy joining the team. “Ravi’s experience in developing innovative products aligns with our mission and values,” said Khawar. “We are thrilled to have him on board.”

The Moda-flxTM Hemodialysis System is developed by Diality and aims to provide healthcare professionals with the tools to make patient-centered decisions and improve clinical practice. Parthasarathy shared his enthusiasm for contributing to the development of this system, highlighting the importance of innovation in improving the quality of life and care for dialysis patients.

Based in Irvine, California, Diality focuses on developing the Moda-flxTM Hemodialysis System which is not currently approved for sale in any region yet . For more information please visit www.diality.com or find Diality on LinkedIn . For media inquiries please contact Sam Choinski at Pazanga Health Communications at schoinski@pazangahealth.com or (860) 301-5058

Leave a Reply